The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2015

Filed:

Feb. 21, 2011
Applicants:

Nobuyuki Ise, Tokyo, JP;

Kazuya Omi, Tokyo, JP;

Daisuke Nambara, Tokyo, JP;

Inventors:

Nobuyuki Ise, Tokyo, JP;

Kazuya Omi, Tokyo, JP;

Daisuke Nambara, Tokyo, JP;

Assignee:

FUJIREBIO INC., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 15/86 (2006.01); C12N 15/87 (2006.01); C12N 5/00 (2006.01); C12N 5/071 (2010.01); G01N 33/50 (2006.01); C12N 5/09 (2010.01); C12Q 1/48 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5011 (2013.01); C12N 5/0693 (2013.01); C12Q 1/48 (2013.01); G01N 33/5023 (2013.01); C12N 2501/998 (2013.01);
Abstract

The present invention provides a methodology that can develop a more excellent anti-cancer drug than conventional ones for various cancers. Specifically, the present invention provides a method for establishing an artificial cell, comprising treating a cancer cell with an expression vector for a foreign oncogene and then culturing the cancer cell treated with the expression vector under a condition which inhibits an expression or function of an oncogene that is inherent to the cancer cell, and an established artificial cell; a method of screening an anti-cancer drug, comprising evaluating whether or not a test substance inhibits a proliferation of the artificial cell; as well as a method for identifying an oncogene, comprising treating a cancer cell with an expression vector for a test gene and then culturing the cancer cell treated with the expression vector under a condition which inhibits an expression or function of an oncogene that is inherent to the cancer cell.


Find Patent Forward Citations

Loading…